Analysis-Prices for new US drugs rose 35% in 2023, more than the previous year
By Deena Beasley (Reuters) – Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022,…
By Deena Beasley (Reuters) – Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022,…
By David Shepardson and Jasper Ward WASHINGTON (Reuters) -The U.S. Federal Trade Commission said Friday it filed a complaint accusing…
(Reuters) -Ratings agency S&P on Friday placed Paramount Global’s credit rating on a negative watch, citing low operating cash flow…
By Aditya Soni and Patturaja Murugaboopathy (Reuters) -Nvidia briefly hit $2 trillion in market value for the first time on…
By Noel Randewich and Medha Singh (Reuters) -Nvidia added $277 billion in stock market value on Thursday, Wall Street’s largest…